Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases

被引：0
|
作者：
Guanyue Su [1 ]
Feng Gao [1 ]
Mengzhao Yang [1 ]
Ling Wang [2 ]
Lili Liang [3 ]
Silin Li [4 ]
Guangming Li [5 ]
Na Han [1 ]
Guotao Li [6 ]
Guowu Qian [7 ]
Shixi Zhang [8 ]
Hong Luo [9 ]
Donghua Zhang [10 ]
Hongxia Liang [1 ]
Zhigang Ren [1 ]
机构：
[1] the First Affiliated Hospital of Zhengzhou University,Department of Infectious Diseases, State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory
[2] Henan Provincial Chest Hospital Affiliated of Zhengzhou University,Department of Clinical Laboratory
[3] Henan Provincial Chest Hospital Affiliated of Zhengzhou University,Department of Medical Information
[4] Fengqiu County People’s Hospital,Department of Respiratory and Critical Care Medicine
[5] the Affiliated Infectious Disease Hospital of Zhengzhou University,Department of Liver Disease
[6] Luoyang Central Hospital Affiliated of Zhengzhou University,Department of Infectious Diseases
[7] Nanyang Central Hospital,Department of Gastrointestinal Surgery
[8] Shangqiu Municipal Hospital,Department of Infectious Diseases
[9] Guangshan County People’s Hospital,Department of Infectious Diseases
[10] Guangshan County,undefined
[11] Anyang City Fifth People’s Hospital,undefined
来源：
Virology Journal | / 22卷 / 1期
关键词：
SARS-CoV-2; Azvudine; Paxlovid; Chronic liver disease; Effectiveness;
D O I：
10.1186/s12985-025-02771-1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study
    Torti, Carlo
    Olimpieri, Pier Paolo
    Bonfanti, Paolo
    Tascini, Carlo
    Celant, Simone
    Tacconi, Danilo
    Nicastri, Emanuele
    Tacconelli, Evelina
    Cacopardo, Bruno
    Perrella, Alessandro
    Buccoliero, Giovanni Battista
    Parruti, Giustino
    Bassetti, Matteo
    Biagetti, Carlo
    Giacometti, Andrea
    Erne, Elke Maria
    Frontuto, Maria
    Lanzafame, Massimiliano
    Summa, Valentina
    Spagnoli, Alessandra
    Vestri, Annarita
    Di Perri, Giovanni
    Russo, Pierluigi
    Palu, Giorgio
    LANCET REGIONAL HEALTH-EUROPE, 2023, 31
  • [22] Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants
    Pagliano, Pasquale
    Spera, Annamaria
    Sellitto, Carmine
    Scarpati, Giuliana
    Folliero, Veronica
    Piazza, Ornella
    Franci, Gianluigi
    Conti, Valeria
    Ascione, Tiziana
    EXPERT OPINION ON DRUG DISCOVERY, 2023, : 1301 - 1311
  • [23] Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
    Marjot, Thomas
    Moon, Andrew M.
    Cook, Jonathan A.
    Abd-Elsalam, Sherief
    Aloman, Costica
    Armstrong, Matthew J.
    Pose, Elisa
    Brenner, Erica J.
    Cargill, Tamsin
    Catana, Maria-Andreea
    Dhanasekaran, Renumathy
    Eshraghian, Ahad
    Garcia-Juarez, Ignacio
    Gill, Upkar S.
    Jones, Patricia D.
    Kennedy, James
    Marshall, Aileen
    Matthews, Charmaine
    Mells, George
    Mercer, Carolyn
    Perumalswami, Ponni, V
    Avitabile, Emma
    Qi, Xialong
    Su, Feng
    Ufere, Nneka N.
    Wong, Yu Jun
    Zheng, Ming-Hua
    Barnes, Eleanor
    Barritt, Alfred S.
    Webb, Gwilym J.
    JOURNAL OF HEPATOLOGY, 2021, 74 (03) : 567 - 577
  • [24] Comparing the effectiveness of molnupiravir and nirmatrelvir-ritonavir in non-hospitalized and hospitalized COVID-19 patients with type 2 diabetes: A target trial emulation study
    Wan, Eric Y. F.
    Wong, Zoey C. T.
    Yan, Vincent K. C.
    Chui, Celine S. L.
    Lai, Francisco T. T.
    Li, Xue
    Wong, Ian C. K.
    Chan, Esther W. Y.
    DIABETES OBESITY & METABOLISM, 2024, 26 (10) : 4653 - 4664
  • [25] Safety and Efficacy of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases: A Systematic Review and Meta-Analysis
    Xiao, Guanglin
    He, Taiyu
    Zhang, Biqiong
    Yang, Ziqiao
    Ling, Ning
    Chen, Min
    Zhang, Dazhi
    Hu, Peng
    Zhang, Gaoli
    Peng, Mingli
    Cai, Dachuan
    Ren, Hong
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2024, 69
  • [26] Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
    Behera, Priyamadhaba
    Singh, Arvind Kumar
    Subba, Sonu Hangma
    Arjun, Mc
    Sahu, Dinesh Prasad
    Chandanshive, Pradnya Dilip
    Pradhan, Somen Kumar
    Parida, Swayam Pragyan
    Mishra, Abhisek
    Patro, Binod Kumar
    Batmanabane, Gitanjali
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [27] Clinical Progression and Outcome of Hospitalized Patients Infected with SARS-CoV-2 Omicron Variant in Shanghai, China
    Shao, Jiasheng
    Fan, Rong
    Hu, Jianrong
    Zhang, Tiejun
    Lee, Catherine
    Huang, Xuyuan
    Wang, Fei
    Liang, Haiying
    Jin, Ye
    Jiang, Ying
    Gu, Yanhua
    Huang, Gang
    VACCINES, 2022, 10 (09)
  • [28] Effectiveness of tixagevimab/cilgavimab in reducing SARS-CoV-2 infections, hospitalizations and mortality in inmunocompromised patients
    Marti-Pastor, Marc
    Bou-Monterde, Ricardo
    Ciancotti-Oliver, Lucia
    Alcover-Pons, Marta
    Cantero, Aurora Amoros
    Sanchez-Lopezosa, Raquel
    Montanana-Rosell, Neus
    MEDICINA CLINICA, 2024, 163 (06): : 275 - 280
  • [29] Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination
    Nevola, Riccardo
    Criscuolo, Livio
    Beccia, Domenico
    Delle Femine, Augusto
    Ruocco, Rachele
    Imbriani, Simona
    Alfano, Maria
    Villani, Angela
    Russo, Antonio
    Perillo, Pasquale
    Marfella, Raffaele
    Adinolfi, Luigi Elio
    Sasso, Ferdinando Carlo
    Marrone, Aldo
    Rinaldi, Luca
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (05) : 800 - 814
  • [30] SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
    Duengelhoef, Paul
    Hartl, Johannes
    Ruether, Darius
    Steinmann, Silja
    Brehm, Thomas T.
    Weltzsch, Jan Philipp
    Glaser, Fabian
    Schaub, G. M.
    Sterneck, Martina
    Sebode, Marcial
    Weiler-Normann, Christina
    Addo, Marylyn M.
    Luetgehetmann, Marc
    Haag, Friedrich
    Schramm, Christoph
    zur Wiesch, Julian Schulze
    Lohse, Ansgar W.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2022, 10 (03) : 319 - 329
12345